Among metastatic tumors from GENIE, TP53 had the highest pathogenic SNV frequency in both BRCA2d and BRCA2i tumors (25.9% vs. 35.6%, padj = 0.07) (Fig. 3c, d, Supplementary Table 7). The gene discussed is TP53; the disease is metastatic neoplasm.